These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31037867)

  • 1. Comparison of cobas
    Han AL; Kim HR; Choi KH; Hwang KE; Zhu M; Huang Y; Wu M; Lee YJ; Park MC; Cho JH; Park DS
    Ann Lab Med; 2019 Sep; 39(5):478-487. PubMed ID: 31037867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Combined test using both cell sediment and supernatant cell-free DNA in pleural effusion shows increased sensitivity in detecting activating EGFR mutation in lung cancer patients.
    Kawahara A; Fukumitsu C; Azuma K; Taira T; Abe H; Takase Y; Murata K; Sadashima E; Hattori S; Naito Y; Akiba J
    Cytopathology; 2018 Apr; 29(2):150-155. PubMed ID: 29363841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Epidermal Growth Factor Receptor Gene Mutations Identified Using Pleural Effusion and Primary Tumor Tissue Samples in Non-Small Cell Lung Cancer.
    Liu N; Sun RZ; Du J; Dong QZ; Fan CF; Li QC; Wang EH; Liu Y
    Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):e44-e51. PubMed ID: 28800007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening system for epidermal growth factor receptor mutation detection in cytology cell-free DNA of cerebrospinal fluid based on assured sample quality.
    Kawahara A; Abe H; Murata K; Ishii H; Azuma K; Takase Y; Hattori S; Naito Y; Akiba J
    Cytopathology; 2019 Mar; 30(2):144-149. PubMed ID: 30471155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of SuperARMS EGFR Mutation Detection Kit to Detect EGFR in Plasma Cell-free DNA of Patients With Lung Adenocarcinoma.
    Cui S; Ye L; Wang H; Chu T; Zhao Y; Gu A; Xiong L; Shi C; Jiang L
    Clin Lung Cancer; 2018 May; 19(3):e313-e322. PubMed ID: 29329944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of epidermal growth factor receptor gene mutation in lung adenocarcinoma using biopsied tissue, pleural effusion and blood samples].
    Shi Y; Ma ZP; Cui WL; Pang XL; Zhang W; Ma YQ
    Zhonghua Bing Li Xue Za Zhi; 2018 Oct; 47(10):775-779. PubMed ID: 30317733
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of EGFR mutation status in malignant pleural effusion and plasma from patients with advanced lung adenocarcinoma.
    Son SM; Woo CG; Han HS; Lee KH; Lim YH; Lee OJ
    Clin Chem Lab Med; 2020 Aug; 58(9):1547-1555. PubMed ID: 32229655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA.
    Lee JS; Hur JY; Kim IA; Kim HJ; Choi CM; Lee JC; Kim WS; Lee KY
    BMC Cancer; 2018 Dec; 18(1):1236. PubMed ID: 30526536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of real-time PCR method for detection of EGFR mutation using both supernatant and cell pellet of malignant pleural effusion samples from non-small-cell lung cancer patients.
    Shin S; Kim J; Kim Y; Cho SM; Lee KA
    Clin Chem Lab Med; 2017 Oct; 55(12):1962-1969. PubMed ID: 28306520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of the detection of
    Zhu Y; Zhu F; Wang L; Zhai X; Shan X
    Indian J Pathol Microbiol; 2021; 64(1):107-110. PubMed ID: 33433418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer.
    Malapelle U; Sirera R; Jantus-Lewintre E; Reclusa P; Calabuig-Fariñas S; Blasco A; Pisapia P; Rolfo C; Camps C
    Expert Rev Mol Diagn; 2017 Mar; 17(3):209-215. PubMed ID: 28129709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of EGFR Mutations in Circulating Tumor DNA (ctDNA) Retrieved from Plasma - Interlaboratory Quality Assessment in the Czech Republic.
    Linda Č; Markéta K; Ivana T; Eva P; Milada M; Hana V; Ondřej H; Karolína B; Jiří D; Monika B; Pavel D
    Klin Onkol; 2018; 31(5):353-360. PubMed ID: 30541321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma ctDNA Analysis for Detection of the EGFR T790M Mutation in Patients with Advanced Non-Small Cell Lung Cancer.
    Jenkins S; Yang JC; Ramalingam SS; Yu K; Patel S; Weston S; Hodge R; Cantarini M; Jänne PA; Mitsudomi T; Goss GD
    J Thorac Oncol; 2017 Jul; 12(7):1061-1070. PubMed ID: 28428148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe.
    Keppens C; Palma JF; Das PM; Scudder S; Wen W; Normanno N; van Krieken JH; Sacco A; Fenizia F; Gonzalez de Castro D; Hönigschnabl S; Kern I; Lopez-Rios F; Lozano MD; Marchetti A; Halfon P; Schuuring E; Setinek U; Sorensen B; Taniere P; Tiemann M; Vosmikova H; Dequeker EMC
    J Mol Diagn; 2018 Jul; 20(4):483-494. PubMed ID: 29704571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of the cobas EGFR Mutation Assay in Non-small-cell Lung Cancer Compared With Three Laboratory-developed Tests.
    Nakamura H; Koizumi H; Sakai H; Kimura H; Miyazawa T; Marushima H; Saji H; Takagi M
    Clin Lung Cancer; 2018 Mar; 19(2):170-174. PubMed ID: 29150249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS.
    Arriola E; Paredes-Lario A; García-Gomez R; Diz-Tain P; Constenla M; García-Girón C; Márquez G; Reck M; López-Vivanco G
    Clin Transl Oncol; 2018 Oct; 20(10):1261-1267. PubMed ID: 29623586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting outcomes of EGFR-targeted therapy in non-small cell lung cancer patients using pleural effusions samples and peptide nucleic acid probe assay.
    Wang MC; Wang CL; Chen TL; Chang JW; Lu JJ; Chang PY; Chiou CC
    Clin Chem Lab Med; 2017 Oct; 55(12):1979-1986. PubMed ID: 28787267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
    Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
    Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of epidermal growth factor receptor gene T790M mutation in cytology samples using the cobas
    Satouchi M; Tanaka H; Yoshioka H; Shimokawaji T; Mizuno K; Takeda K; Yoshino I; Seto T; Kurata T; Tashiro N; Hagiwara K
    Lung Cancer; 2017 Sep; 111():190-194. PubMed ID: 28838392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of plasma and tissue samples in epidermal growth factor receptor mutation by ARMS in advanced non-small cell lung cancer.
    Ma M; Shi C; Qian J; Teng J; Zhong H; Han B
    Gene; 2016 Oct; 591(1):58-64. PubMed ID: 27370697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.